Human Genome Epidemiology Literature Finder
Pharmacogenomics
|
Records 1 - 30 (of 909 Records) |
| Query Trace: Clopidogrel[original query] |
|---|
| Genetic Determinants of Response to P2Y Inhibitors and Clinical Implications. Interventional cardiology clinics 2024 9 13 (4): 469-481. Larisa H Cavallari, James C Coo |
| Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Drugs 2024 9 . Dominique P M S M Maas, Loes H Willems, Josephine Kranendonk, Cornelis Kramers, Michiel C War |
| [Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2024 9 62 (10): 981-988. Y Y Cao, Q Y Pan, J Li, X F Zhong, X C Liang, L He, C Chu, Q M Zhao, L Zhao, F Wang, S N Sun, Y X Lin, G Y Huang, F L |
| High Frequency of CYP2C19*3 Heterozygotes Among Patients Under Clopidogrel Treatment in Ouagadougou, Burkina Faso. Pakistan journal of biological sciences : PJBS 2024 9 27 (8): 398-403. Abdoul Karim Ouattara, Yves Donald Kagambega, Teega-Wende Clarisse Ouedraogo, Lassina Traore, Modeste Ouedraogo, Nobila Valentin Yameogo, Jacques Simpo |
| Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week. Journal of the American College of Cardiology 2024 9 84 (12): 1107-1118. Wout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, Craig R Lee, Larisa H Cavallari, Jesse J Swen, Dominick J Angiolillo, Jurriën M Ten Be |
| Real-World Implementation of a Genotype-Guided P2Y Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients. JACC. Cardiovascular interventions 2024 9 . Jaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, Niels M R van der Sangen, Shabiga Sivanesan, Salahodin Bofarid, Joyce Peper, Daniel M F Claassens, Paul W A Janssen, Ankie M Harmsze, Ronald J Walhout, Melvyn Tjon Joe Gin, Deborah M Nicastia, Jorina Langerveld, Georgios J Vlachojannis, Rutger J van Bommel, Yolande Appelman, Ron H N van Schaik, José P S Henriques, Wouter J Kikkert, Jurriën M Ten Be |
| Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach. International journal of cardiology 2024 8 414 132418. Ruchika Sharma, Geeta Aggarwal, Anoop Kumar, Ajit K Thakur, Mahak Pandit, Varun Sharma, Manmohan Singh, Jaseela Majeed, Puneeta Ajme |
| Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies. Clinical and translational science 2024 8 17 (8): e70004. Larisa H Cavallari, Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas, Yan Gong, Caitrin W McDonough, Petr Starostik, Maryam J Al Saeed, Latonya Been, Natasha Kulick, Jean Malave, Ian R Mulrenin, Anh B Nguyen, Joshua N Terrell, Grace Tillotson, Amber L Beitelshees, Almut G Winterstein, George A Stouffer, Dominick J Angiolil |
| Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation. BMC medicine 2024 8 22 (1): 335. Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Tae Hoon Ahn, Young-Hoon Jeong, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun L |
| Can CYP2C19 genotyping improve antiplatelet therapy efficacy in real-life practice? Recent advances. Kardiologia polska 2024 8 . Udaya S Tantry, Sahib Singh, Lekshmi Narayan Raghavakurup, Kevin P Bliden, Paul A Gurb |
| Effect of Ticagrelor Versus Clopidogrel After Off-Pump Coronary Artery Bypass Grafting on Postoperative Atrial Fibrillation: A Cohort Study. Journal of the American Heart Association 2024 8 e035424. Qin Jiang, Keli Huang, Lixue Yin, Hong Kong, Zhenglin Yang, Shengshou |
| The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine. The application of clinical genetics 2024 7 17 95-105. Vorthunju Nakhonsri, Shobana John, Hathaichanok Panumasmontol, Manassanan Jantorn, Pongpipat Chanthot, Nuntachai Hanpramukkun, Supaporn Meelarp, Chonlaphat Sukasem, Sissades Tongsima, Sukhontha Hasatsri, Abhisit Prawang, Thanawat Thaingtamtanha, Natchaya Vanwong, Chalirmporn Atasilp, Monpat Chamnanphon, Pimonpan Jinda, Patompong Satapornpo |
| Pharmacogenomic Polygenic Model of Clopidogrel Predicts Recurrent Ischemic Events in Chinese Patients With Coronary Artery Disease. Clinical therapeutics 2024 7 . Xinyi Zhang, Yuchun Cai, Pei Zhou, Wenchang Nie, Haoning Sun, Yutong Sun, Yuxuan Zhao, Congxiao Han, Chengfu Cao, Jian Liu, Xiaoyan N |
| [Clinical analysis of dual enhanced antiplatelet therapy after cerebrovascular intervention for reducing the risk of cerebral infarction recurrence]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2024 7 58 (7): 1062-1068. Y Liu, Y Y Yin, Q L Lu, C Li, C Y Zha |
| Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction. Clinical pharmacology and therapeutics 2024 7 . Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte, Yan Gong, Joseph S Rossi, Amber L Beitelshees, George A Stouffer, Craig R Lee, Dominick J Angiolillo, Larisa H Cavalla |
| Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome. Indian heart journal 2024 7 . Heemanshu Lodhi, Keshavamurthy Ganapathy Bhat, Vivek Singh Guleria, Ratheesh Kumar Janardhana Pillai, Ribhu Goel, Nitin Sharma, Anuka Sharma, Varun Shar |
| Exploring the impact of pharmacogenetics on personalized medicine: A systematic review. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 2024 6 . Laura Amaro-Alvarez, Jaime Cordero-Ramos, Miguel Ángel Calleja-Hernánd |
| Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology. BMC pharmacology & toxicology 2024 6 25 (1): 34. Pengfei Li, Mengying Cao, Ling Liu, Long Chen, Shuang Liang, Youbin Wa |
| The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence. Journal of stroke 2024 6 26 (2): 231-241. Qin Xu, Xia Meng, Hao Li, Xuewei Xie, Jing Jing, Jinxi Lin, Yong Jiang, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Anxin Wang, Yongjun Wa |
| The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study. BMC neurology 2024 6 24 (1): 216. Rakhmad Hidayat, Rizqi Amanda Nabilah, Marc Fisher, Tiara Aninditha, Mohammad Kurniawan, Riwanti Estiasari, Luh Ari Indrawati, Ahmad Yanuar Safri, Taufik Mesiano, Al Rasyid, Salim Harr |
| CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association. Circulation 2024 6 . Naveen L Pereira, Sharon Cresci, Dominick J Angiolillo, Wayne Batchelor, Quinn Capers, Larisa H Cavallari, Dana Leifer, Jasmine A Luzum, Dan M Roden, Konstantinos Stellos, Stephanie L Turrise, Sony Tuteja, |
| Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention. Pharmacogenomics 2024 6 1-6. Joshua J Park, Gervacio Y Cabel, Kevin K Cheng, Jefferson Dang, Amer K Ardati, Jin Han, James C L |
| Association of genetic variations of 3'-UTR in clopidogrel pharmacokinetic-relevant genes with clopidogrel response in Han Chinese patients with coronary artery disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2024 6 200 106830. Dongjie Li, Boyu Xiang, Jingxuan Peng, He Li, Liming Peng, Xiaoping Ch |
| Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial. Stroke 2024 6 . Xuewei Xie, Jing Jing, Xia Meng, S Claiborne Johnston, Philip M Bath, Zixiao Li, Xingquan Zhao, Yilong Wang, Qin Xu, Anxin Wang, Yong Jiang, Hao Li, Yongjun Wang, |
| Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 2024 5 15 (5): . Lana Ganoci, Jozefina Pali?, Vladimir Trkulja, Katarina Star?evi?, Livija Šimi?evi?, Nada Božina, Martina Lovri?-Ben?i?, Zdravka Poljakovi?, Tamara Boži |
| Prognostic Impact of CYP2C19 Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention. Journal of the American Heart Association 2024 5 13 (10): e032248. Ju Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Ahn, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Young-Hoon Jeong, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun Lim, |
| The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis. Clinical and translational science 2024 4 17 (4): e13792. Mohitosh Biswas, Md Shahadat Hossain, Tahsin Ahmed Rupok, Md Sabbir Hossain, Chonlaphat Sukas |
| Genetic variability in stroke patients: CYP2C19 polymorphisms unraveled. BMC medical genomics 2024 4 17 (1): 109. Peiyi Peng, Yingxiu Xiao, Xuehong Peng, Jianqiang Chen, Nuan Ch |
| The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis. Cerebrovascular diseases extra 2025 1 1-12. Songchai Kittipanprayoon, Pongpat Vorasayan, Aurauma Chutinet, Pajaree Chariyavilaskul, Nijasri C Suwanwe |
| CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka. Pharmacogenomics 2025 1 1-4. Priyanga Ranasinghe, Pulasthi B Gunarathna, Hajanthy Jeyapragasam, Nirmala Sirisena, D P Bhagya Hendalage, Vajira H W Dissanaya |
- Page last reviewed:Feb 1, 2024
- Content source: